Azenta Life Sciences (AZTA) CEO On Life Sciences
b'Azenta Life Sciences (AZTA) stock price is up over 46% year-to-date. The company is set to sell its semiconductor automation business in the first half of 2022. CEO Dr. Stephen Schwartz weighs in on why Azenta Life Sciences (AZTA) is focusing on life sciences. Additionally, he provides the outlook for the company moving forward.'